Cargando…
Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
Clinical study endpoints that assess the efficacy of interventions in patients with chronic renal insufficiency can be adopted for use in kidney transplantation trials, given the pathophysiological similarities between both conditions. Kidney dysfunction is reflected in the glomerular filtration rat...
Autores principales: | Hilbrands, Luuk, Budde, Klemens, Bellini, Maria Irene, Diekmann, Fritz, Furian, Lucrezia, Grinyó, Josep, Heemann, Uwe, Hesselink, Dennis A., Loupy, Alexandre, Oberbauer, Rainer, Pengel, Liset, Reinders, Marlies, Schneeberger, Stefan, Naesens, Maarten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163811/ https://www.ncbi.nlm.nih.gov/pubmed/35669976 http://dx.doi.org/10.3389/ti.2022.10139 |
Ejemplares similares
-
Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022) -
Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022) -
Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation
por: Seron, Daniel, et al.
Publicado: (2022) -
Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation
por: Roufosse, Candice, et al.
Publicado: (2022) -
Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions
por: Tong, Allison, et al.
Publicado: (2022)